Breaking News
4 hours ago
Simantini Singh Deo
Vor Biopharma adds Andrew Levin and Wouter Joustra to its Board, strengthening investment and governance expertise as Phase 3 programs advance.
Simantini Singh Deo
Pelthos appoints Andrew Einhorn to its Board of Directors, adding over four decades of financial and life sciences leadership.
Simantini Singh Deo
Dyne appoints biotech executive Vikram Karnani to its Board, adding deep commercialization and rare disease leadership expertise.
Simantini Singh Deo
Wayrilz gains EU approval for treating adults with refractory ITP, offering a multi-immune modulation approach beyond platelet control.
Simantini Singh Deo